within Pharmacolibrary.Drugs.ATC.C;

model C01DA14
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.93,
    Cl             = 6.666666666666666e-07,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,
    adminCount     = 1,
    Vd             = 0.0006,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.014466666666666666,
    Tlag           = 9.6
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>ATC code:</td><td>C01DA14</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Isosorbide mononitrate is an organic nitrate used for the prophylactic treatment of angina pectoris due to coronary artery disease. It acts as a vasodilator, reducing myocardial oxygen demand, and is approved for use in the management of angina.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after oral administration of a single dose.</p><h4>References</h4><ol><li><p>Liu, Z, et al., &amp; Guo, R (2015). CGRP mediate the isosorbide-5-mononitrate cardiovascular response in healthy Chinese male volunteers through a XOR-independent pathway. <i>International journal of clinical pharmacology and therapeutics</i> 53(4) 325â€“334. DOI:<a href=\"https://doi.org/10.5414/CP202178\">10.5414/CP202178</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25740261/\">https://pubmed.ncbi.nlm.nih.gov/25740261</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>"
  ));
end C01DA14;
